scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "COST control"

1 - 10 of 184,932 results for
 "COST control"
Results per page:

Budget cap and pay-back model to control spending on medicines: A case study of Bulgaria.

Publication Type: Academic Journal

Source(s): Frontiers in public health [Front Public Health] 2022 Nov 11; Vol. 10, pp. 1011928. Date of Electronic Publication: 2022 Nov 11 (Print Publication: 2022).

Abstract: Central and Eastern European countries (CEEC) have among the highest rates of increase in healthcare expenditure. External reference pricing, generics and biologics price capping, regressive scale for price setting, health technology assessment (HTA), ...

View details

Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals.

Publication Type: Academic Journal

Source(s): Health economics, policy, and law [Health Econ Policy Law] 2022 Jul; Vol. 17 (3), pp. 348-365. Date of Electronic Publication: 2022 Apr 06.

Abstract: This paper explores policy mechanisms behind New Zealand's remarkable track record of cost containment in public pharmaceutical spending, contrasting with most other advanced economies. We drew on a review of official policy documents and 28 semi-struc...

View details

Cost-consciousness among Chinese medical staff: a cross-sectional survey.

Publication Type: Academic Journal

Source(s): BMC health services research [BMC Health Serv Res] 2022 Jun 06; Vol. 22 (1), pp. 752. Date of Electronic Publication: 2022 Jun 06.

Authors:

Abstract: Background: Rapidly increasing health care costs are a widespread problem in the world. The cost-consciousness among Chinese medical staff is an important topic that needs further investigation. Our study aimed to focus on the cost-consciousness of Chi...

View details

Cost sharing: implications of a well-intended benefits strategy.

Publication Type: Academic Journal

Source(s): Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2022 Feb; Vol. 28 (2), pp. 275-277.

Authors:

Abstract: DISCLOSURES: The thoughts and opinions expressed in this article are those of the author only and are not the thoughts and opinions of any current or former employer of the author. Nor is this publication made by, on behalf of, or endorsed or approved ...

View details

Artificial neural networks for intelligent cost estimation – a contribution to strategic cost management in the manufacturing supply chain.

Publication Type: Academic Journal

Source(s): International Journal of Production Research. Nov2022, Vol. 60 Issue 21, p6637-6658. 22p. 10 Diagrams, 6 Charts, 6 Graphs.

Abstract: In today's complex supply networks sharing information between buyers and suppliers is critical for sustainable competitive advantage. In particular, for both business partners, cost information is highly relevant in purchasing situations. According to...

View details

[French national overview of the inclusion of environmental criteria in the public purchasing of health products (drugs and sterile medical devices)].

Publication Type: Academic Journal

Source(s): Annales pharmaceutiques francaises [Ann Pharm Fr] 2022 Mar; Vol. 80 (2), pp. 216-226. Date of Electronic Publication: 2021 Jun 18.

Abstract: Objectives: Healthcare products (HP) have a significant carbon footprint that must be included by regulation in the facility's purchasing policy. A national overview of the inclusion of environmental criteria (EC) in the public procurement (PP) of HP i...

View details

How value-based policy interventions influence price negotiations for new medicines: An experimental approach and initial evidence.

Publication Type: Academic Journal

Source(s): Health policy (Amsterdam, Netherlands) [Health Policy] 2022 Feb; Vol. 126 (2), pp. 112-121. Date of Electronic Publication: 2021 Dec 31.

Authors:

Abstract: Background: Various forms of value-based pricing policies for new medicines have recently been introduced in OECD countries. While these initiatives are expected to have a positive impact on societal outcomes such as availability, affordability and val...

View details

Classification of Pharmaceutical Policy Measures During the Portuguese Financial Crisis.

Publication Type: Academic Journal

Source(s): Inquiry : a journal of medical care organization, provision and financing [Inquiry] 2022 Jan-Dec; Vol. 59, pp. 469580221093171.

Abstract: Background: A rise in pharmaceutical expenses in Portugal led to the introduction of policy measures aimed at controlling outpatient public costs. This research examines and categorizes the most common pharmaceutical measures implemented during the Tro...

View details

Insulin - the new battleground for drug pricing.

Publication Type: Editorial & Opinion

Source(s): Nature biotechnology [Nat Biotechnol] 2022 Jan; Vol. 40 (1), pp. 1.

View details

An urgent call to raise the bar in oncology.

Publication Type: Academic Journal

Source(s): British journal of cancer [Br J Cancer] 2021 Nov; Vol. 125 (11), pp. 1477-1485. Date of Electronic Publication: 2021 Aug 16.

Abstract: Important breakthroughs in medical treatments have improved outcomes for patients suffering from several types of cancer. However, many oncological treatments approved by regulatory agencies are of low value and do not contribute significantly to cance...

View details
sponsored